Dissecting Neurocognitive Components of Compulsivity Using Computational Modeling and EEG

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Psychiatric disorders characterized by compulsivity, such as obsessive-compulsive disorder (OCD), result in considerable functional impairment and many individuals do not respond to gold-standard treatments. Compulsivity has long been thought to occur due to exaggerated habits and reduced goal-directed control, although more recently, this conceptualization of compulsivity as an imbalance of two cognitive systems has been challenged as overly narrow. This study will recruit 100 individuals (50 adults diagnosed with OCD, 50 healthy controls) and leverage the measurement precision offered by theory-driven computational modeling in combination with electroencephalogram (EEG) to go beyond this binary theory of compulsivity, revealing how more complex interactions of neurocognitive subcomponents contribute to compulsivity-information that could ultimately lead to improved treatment personalization and clinical outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:

⁃ Participants must be:

• between the ages 18-55 years old

• English-speaking

• right-handed

• able to provide consent

Locations
United States
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Contact Information
Primary
Amy Rapp, Ph.D.
OCDResearch@mssm.edu
212-241-5288
Time Frame
Start Date: 2025-07-09
Estimated Completion Date: 2030-03-31
Participants
Target number of participants: 100
Treatments
Experimental: Participants diagnosed with OCD
All participants diagnosed with Obsessive Compulsive Disorder (OCD) who enroll in this study will receive 17 sessions of exposure and response prevention, a specialized cognitive behavioral therapy for OCD, over the course of 10 weeks.
No_intervention: Healthy controls
Individuals who do not have a current or lifetime psychiatric diagnosis will not receive any treatment.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Mental Health (NIMH)
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov